Journal Indexes Journal Indexes
Saved0
All
By index By subject →

Citation indexes

ScopusQ1–Q4 quartiles, CiteScore Web of ScienceSCIE, SSCI, AHCI, ESCI

Business rankings

ABDCRated A* to C ABS / AJGGraded 4* to 1

Open access

DOAJOpen-access journals

Elite lists

UTD 24UT Dallas research list FT50Financial Times 50

India

ONOSRead and publish free
Article IndexesAuthor Indexes
Journal FinderFind, vet and target the right journalKey Journal IndexesFT50, ABDC, Scopus, WoS and DOAJ explainedPredatory Journal CheckerRed flags, lists and tools before you submitPublication Fees (APC)What Scopus journals charge, free ones firstData ReportsOriginal numbers on fees and Scopus coverageMethodologySources, dates and how journals are matchedIndex ChangesWhat was added to or removed from each index
Sources BlogCommunityAbout Saved0
October 2026 52,299 journals indexed.
Back
Share
Visit journal website ↗ Community

Compare journals

    Get an email when this journal's indexing changes

    Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.

    Oncogematologiya

    Oncogematologiya is Scopus-indexed (Q4, CiteScore 0.6). Published by ABV-press Publishing House.

    Checked against the index lists dated 4 October 2026.

    ISSN 1818-8346Verify ISSN ↗2413-4023Verify ISSN ↗

    Publisher: ABV-press Publishing House

    Scopus · Q4
    0.6
    CiteScore 2025
    Scopus
    Q4
    Best quartile
    rank 128 of 151 · 15th pctile
    1
    Indexed in
    major index

    Cost to publish: No APC data — check the publisher

    ScopusElsevier Scopus
    Status
    Active
    Coverage
    2017–present
    Source type
    Journal
    Open access
    No
    CiteScore
    0.6
    SJR · SCImago
    0.127
    Q4 SJR quartile
    H-index
    8
    Best quartile
    Q4 · 15th pctile
    Subject areaRankPctileQ
    Hematology128 / 15115thQ4
    Oncology367 / 42814thQ4
    View this source on Scopus.com
    DOAJDirectory of Open Access Journals (live)
    Not in DOAJ
    Open accessNot registered as fully open access

    Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)

    Quick answers

    Is Oncogematologiya indexed in Scopus?

    Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q4, CiteScore 0.6.

    What quartile is Oncogematologiya in Scopus?

    Oncogematologiya is Q4 in Hematology (rank 128 of 151) and Q4 in Oncology (rank 367 of 428), by CiteScore 2025.

    What is the impact factor of Oncogematologiya?

    Oncogematologiya is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.6, quartile Q4, 15th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.127, quartile Q4, with an H-index of 8.

    Who publishes Oncogematologiya and what is its ISSN?

    Oncogematologiya is published by ABV-press Publishing House. Its print ISSN is 1818-8346 and its online ISSN is 2413-4023.

    Is Oncogematologiya in Web of Science?

    No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).

    Is Oncogematologiya open access?

    No — it is not registered as an open-access journal in DOAJ or Scopus.

    How well cited is Oncogematologiya? — open metrics via OpenAlex

    Oncogematologiya has an h-index of 12 and a 2-year mean of 0.49 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q4. On 2-year citations it ranks #112 of 148 Scopus journals in Hematology.

    12
    h-index
    0.49
    2-yr mean citations
    15
    i10-index
    721
    works indexed
    974
    total citations
    2-yr mean citations, among Scopus journals in the same subject
    #112 of 148 Bottom 25% Hematology
    #336 of 424 Bottom 21% Oncology
    Papers published per year
    0501002017: 40 papers4020172018: 44 papers4420182019: 43 papers4320192020: 40 papers4020202021: 45 papers4520212022: 67 papers6720222023: 62 papers6220232024: 74 papers7420242025: 54 papers5420252026: 22 papers so far222026*

    Oncogematologiya published 54 papers in 2025; its busiest recent year was 2024 with 74. 2026* is the year so far.

    Main topics
    Legal and Regulatory AnalysisLinguistic, Cultural, and Literary StudiesMilitary Technology and StrategiesLymphoma Diagnosis and Treatment

    h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.

    Who publishes in Oncogematologiya? — latest 98 articles, 2024–2026

    In its latest 98 research articles (2024–2026), authors are most often from Russia (98%), Kazakhstan (1%) and France (0.5%). More than half of recent authorship comes from one country.

    Author countriesRussiaRussia98%KazakhstanKazakhstan1%FranceFrance0.5%UzbekistanUzbekistan0.5% Most frequent institutions (papers)Ministry of Health of the Russian FederationMinistry of Health of the Russi…77National Medical Research Center for HematologyNational Medical Research Cente…36Sechenov UniversitySechenov University17Russian Medical Academy of Continuous Professional EducationRussian Medical Academy of Cont…16Russian Cancer Research Center NN BlokhinRussian Cancer Research Center …13

    Countries are counted fractionally, so a paper by authors from two countries counts half to each.

    Are there integrity warnings for Oncogematologiya? — indicators, not proof of misconduct

    Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.

    • Scopus statusActive
    • Retracted papers None recorded
    • Problematic Paper Screener flags None flagged
    • Author concentration98% of recent authorship from Russia

    Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.

    Official sources & links

    Journal website ↗ Scopus source ↗ ISSN Portal · 1818-8346 ↗ISSN Portal · 2413-4023 ↗

    Community experience: reader comments on this journal

    Comments load as you scroll here.

    Related journals

    8 journals
    Journal Indexed in
    Onkourologiya Scopus Q4 WoS ESCI Opuholi Golovy i Sei Scopus Q4 Opuholi Zenskoj Reproduktivnoj Sistemy Scopus Q4 Rossijskij Bioterapevticeskij Zurnal Scopus Q4 Russian Journal of Neurosurgery Scopus Q4 Russkii Zhunal Detskoi Nevrologii Scopus Q4 Sarkomy Kostej, Magkih Tkanej i Opuholi Kozi Scopus Q4 Uspehi Molekularnoj Onkologii Scopus Q4
    ← Back to Journal Finder

    Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.

    Journal Indexes

    Free lookup of 52,000+ academic journals across Scopus, Web of Science, ABDC, ABS / AJG, DOAJ, FT50, UT Dallas 24 and ONOS — check a journal before you submit.

    Research

    Journal Finder Journals by Subject Publishing Toolkit Key Journal Indexes Predatory Journal Checker Publication Fees (APC)

    Monthly Visitors

    ···

      Contact us

      Questions or feedback? Let's talk.

      We read every message — typically replying within 48 hours.

      Send us a message

      Or write to contact@journalindexes.com

      Parent siteYuvijenyuvijen.com

      On Yuvijen

      Learn

      Free Books Blog Data Analytics

      Tools

      Periodic Table Element Reference Distributions P-Value Calculator Sample Size Calculator

      Exam Prep

      Exam Prep Hub UGC NET IPMAT CAT CBSE Class 8

      © 2026 Journal Indexes, a Yuvijen project. All rights reserved. · About Journal Indexes · Methodology · Reports · Community · Terms · Privacy